D-739-2014 Class III Terminated
FDA drug recall D-739-2014 was initiated by Novartis Consumer Health on May 15, 2013 and is designated Class III. Reason for recall: Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing. The recall status is terminated (terminated Nov 4, 2014). Affected quantity: 32,256/24-caplet packages.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 22, 2014
- Initiation Date
- May 15, 2013
- Termination Date
- Nov 4, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 32,256/24-caplet packages
Product description
Maximum Strength Comtrex Nighttime Cold & Cough, Acetaminophen 325mg ,Chlorpheniramine Maleate 2mg, Dextromethorphan HBR 10mg,Phenylephrine HCL 5mg, packaged in 24 coated caplets nighttime formula *includes antihistamine, Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 075054-0622, NDC 0067-2081-24.
Reason for recall
Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.
Distribution pattern
Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.
Code information
Lot # 10119267 exp 07/13 Lot # 10123857 exp 07/13 Lot # 10123888 exp 09/13
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-739-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026